Phase II study of VM 26 in extensively pretreated breast cancer

U. Tirelli, M. G. Trovo, G. Franchin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A significant activity of VM 26 in solid tumors has been established in brain tumors, bladder cancer, and neuroblastoma. Preliminary favorable results in breast cancer stimulated a phase II study at our institution to define the activity of VM 26 in patients with advanced, homogeneously pretreated breast cancer.

Original languageEnglish
Pages (from-to)451-452
Number of pages2
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume7
Issue number5
Publication statusPublished - 1984

Fingerprint

Teniposide
Breast Neoplasms
Neuroblastoma
Urinary Bladder Neoplasms
Brain Neoplasms
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Phase II study of VM 26 in extensively pretreated breast cancer. / Tirelli, U.; Trovo, M. G.; Franchin, G.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 7, No. 5, 1984, p. 451-452.

Research output: Contribution to journalArticle

@article{a35411a8056147ea82cd0c761b5b2b3a,
title = "Phase II study of VM 26 in extensively pretreated breast cancer",
abstract = "A significant activity of VM 26 in solid tumors has been established in brain tumors, bladder cancer, and neuroblastoma. Preliminary favorable results in breast cancer stimulated a phase II study at our institution to define the activity of VM 26 in patients with advanced, homogeneously pretreated breast cancer.",
author = "U. Tirelli and Trovo, {M. G.} and G. Franchin",
year = "1984",
language = "English",
volume = "7",
pages = "451--452",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Phase II study of VM 26 in extensively pretreated breast cancer

AU - Tirelli, U.

AU - Trovo, M. G.

AU - Franchin, G.

PY - 1984

Y1 - 1984

N2 - A significant activity of VM 26 in solid tumors has been established in brain tumors, bladder cancer, and neuroblastoma. Preliminary favorable results in breast cancer stimulated a phase II study at our institution to define the activity of VM 26 in patients with advanced, homogeneously pretreated breast cancer.

AB - A significant activity of VM 26 in solid tumors has been established in brain tumors, bladder cancer, and neuroblastoma. Preliminary favorable results in breast cancer stimulated a phase II study at our institution to define the activity of VM 26 in patients with advanced, homogeneously pretreated breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=0021705692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021705692&partnerID=8YFLogxK

M3 - Article

C2 - 6507365

AN - SCOPUS:0021705692

VL - 7

SP - 451

EP - 452

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 5

ER -